TrialClinical and experimental nephrology2024

Letermovir safety and efficacy for cytomegalovirus prophylaxis in adult Japanese kidney transplant recipients: a multicenter, open-label, noncomparative Phase 3 study.

Hideki Ishida et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.